This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-29a-3p | AKT2 | 0.2 | 0.85995 | -0.01 | 0.98435 | MirTarget | -0.12 | 0.00214 | 24076586 | Furthermore a feed-back loop comprising of c-Myc miR-29 family and Akt2 were found in myeloid leukemogenesis |
2 | hsa-miR-106a-5p | AKT3 | -0.82 | 0.02545 | 0.09 | 0.82989 | miRNATAP | -0.16 | 0.00858 | NA | |
3 | hsa-miR-106b-5p | AKT3 | -0.39 | 0.38964 | 0.09 | 0.82989 | miRNATAP | -0.31 | 0.00102 | NA | |
4 | hsa-miR-107 | AKT3 | -0.29 | 0.76966 | 0.09 | 0.82989 | PITA; miRanda | -0.29 | 0.00414 | NA | |
5 | hsa-miR-335-3p | AKT3 | 0.07 | 0.89349 | 0.09 | 0.82989 | mirMAP | -0.16 | 0.00961 | NA | |
6 | hsa-miR-93-5p | AKT3 | -0.38 | 0.73231 | 0.09 | 0.82989 | miRNATAP | -0.27 | 0.00266 | NA | |
7 | hsa-miR-155-5p | CAB39L | -0.32 | 0.67318 | 0.46 | 0.20249 | miRNAWalker2 validate | -0.12 | 0.00272 | NA | |
8 | hsa-miR-192-5p | CAB39L | -0 | 0.99638 | 0.46 | 0.20249 | miRNAWalker2 validate | -0.16 | 4.0E-5 | NA | |
9 | hsa-miR-342-3p | CAB39L | -0.23 | 0.73996 | 0.46 | 0.20249 | miRanda | -0.17 | 0.00245 | NA | |
10 | hsa-miR-361-5p | CAB39L | -0.28 | 0.72855 | 0.46 | 0.20249 | MirTarget; miRanda | -0.17 | 0.03074 | NA | |
11 | hsa-miR-30e-5p | DDIT4 | -0 | 0.99712 | 0.21 | 0.74135 | MirTarget | -0.23 | 0.00373 | NA | |
12 | hsa-miR-92b-3p | DDIT4 | 0.45 | 0.64619 | 0.21 | 0.74135 | miRNATAP | -0.22 | 0.00019 | NA | |
13 | hsa-miR-15b-5p | EIF4B | 0.25 | 0.79071 | 0.25 | 0.73129 | miRNATAP | -0.12 | 0.00683 | NA | |
14 | hsa-miR-185-5p | EIF4B | -0.65 | 0.11792 | 0.25 | 0.73129 | MirTarget | -0.14 | 1.0E-5 | NA | |
15 | hsa-miR-23b-5p | EIF4B | 0.07 | 0.82803 | 0.25 | 0.73129 | miRNAWalker2 validate | -0.11 | 0.00024 | NA | |
16 | hsa-miR-330-5p | EIF4B | -0.15 | 0.78726 | 0.25 | 0.73129 | miRNATAP | -0.12 | 0.00063 | NA | |
17 | hsa-miR-339-5p | EIF4B | -0.12 | 0.81428 | 0.25 | 0.73129 | miRanda | -0.1 | 0.00325 | NA | |
18 | hsa-miR-342-3p | EIF4B | -0.23 | 0.73996 | 0.25 | 0.73129 | miRanda | -0.18 | 0 | NA | |
19 | hsa-miR-2110 | EIF4E | -0.36 | 0.45154 | 0.32 | 0.37219 | mirMAP | -0.11 | 0.00023 | NA | |
20 | hsa-miR-26a-5p | EIF4E | 0.05 | 0.95522 | 0.32 | 0.37219 | mirMAP | -0.21 | 0 | NA | |
21 | hsa-miR-30c-5p | EIF4E | -0.18 | 0.83318 | 0.32 | 0.37219 | mirMAP | -0.19 | 0 | NA | |
22 | hsa-miR-320c | EIF4E | 0.09 | 0.78554 | 0.32 | 0.37219 | MirTarget; miRanda | -0.12 | 0.00016 | NA | |
23 | hsa-miR-361-5p | EIF4E | -0.28 | 0.72855 | 0.32 | 0.37219 | miRanda; mirMAP | -0.12 | 0.02086 | NA | |
24 | hsa-miR-378a-3p | EIF4E | -0.43 | 0.62879 | 0.32 | 0.37219 | mirMAP | -0.11 | 4.0E-5 | NA | |
25 | hsa-miR-29a-3p | EIF4E2 | 0.2 | 0.85995 | 0.11 | 0.83172 | MirTarget | -0.12 | 0 | NA | |
26 | hsa-miR-125a-5p | EIF4EBP1 | -0.01 | 0.99489 | -0.21 | 0.69191 | miRNAWalker2 validate; MirTarget; miRanda; miRNATAP | -0.26 | 0.00151 | 26646586 | Increased expression of miR-125a and miR-125b inhibited invasion and migration of SKOV3 and OVCAR-429 ovarian cancer cells and was associated with a decrease in EIF4EBP1 expression |
27 | hsa-miR-362-5p | IGF1 | -0.36 | 0.45216 | 0.39 | 0.49442 | mirMAP | -0.14 | 0.02288 | NA | |
28 | hsa-miR-130a-3p | MAPK1 | -0.02 | 0.97739 | -0.3 | 0.62729 | mirMAP | -0.13 | 0.00027 | NA | |
29 | hsa-miR-148b-3p | MAPK1 | 0.09 | 0.91471 | -0.3 | 0.62729 | mirMAP | -0.12 | 0.01943 | NA | |
30 | hsa-miR-342-3p | PDPK1 | -0.23 | 0.73996 | -0.08 | 0.87808 | mirMAP | -0.1 | 0.00367 | NA | |
31 | hsa-miR-34a-5p | PGF | -0.69 | 0.19575 | -0.1 | 0.74683 | miRNATAP | -0.14 | 0.0236 | NA | |
32 | hsa-miR-429 | PGF | -0.6 | 0.12897 | -0.1 | 0.74683 | miRNATAP | -0.16 | 0.00176 | NA | |
33 | hsa-miR-335-3p | PIK3CG | 0.07 | 0.89349 | -0.35 | 0.33299 | mirMAP | -0.16 | 0.00995 | NA | |
34 | hsa-miR-17-5p | PIK3R1 | -0.64 | 0.32067 | 0.18 | 0.73919 | MirTarget; TargetScan; miRNATAP | -0.11 | 0.02188 | NA | |
35 | hsa-miR-221-3p | PIK3R1 | -0.26 | 0.74402 | 0.18 | 0.73919 | MirTarget | -0.21 | 2.0E-5 | NA | |
36 | hsa-miR-222-3p | PIK3R1 | -0.23 | 0.72665 | 0.18 | 0.73919 | MirTarget | -0.21 | 1.0E-5 | NA | |
37 | hsa-miR-629-3p | PIK3R1 | -0.46 | 0.20921 | 0.18 | 0.73919 | MirTarget | -0.18 | 7.0E-5 | NA | |
38 | hsa-miR-28-5p | PIK3R2 | -0.05 | 0.91096 | 0.14 | 0.83378 | miRanda | -0.1 | 0.0459 | NA | |
39 | hsa-miR-423-5p | PIK3R2 | -0.31 | 0.65889 | 0.14 | 0.83378 | MirTarget | -0.12 | 0.02884 | NA | |
40 | hsa-miR-1271-5p | PIK3R3 | -0.12 | 0.70353 | -0.03 | 0.95678 | mirMAP | -0.2 | 0.0004 | NA | |
41 | hsa-miR-92a-3p | PIK3R3 | 0.02 | 0.99144 | -0.03 | 0.95678 | MirTarget; miRNATAP | -0.3 | 0.00023 | NA | |
42 | hsa-miR-92b-3p | PIK3R3 | 0.45 | 0.64619 | -0.03 | 0.95678 | MirTarget; miRNATAP | -0.18 | 0.00061 | NA | |
43 | hsa-miR-130a-3p | PRKAA1 | -0.02 | 0.97739 | 0 | 0.99281 | MirTarget; miRNATAP | -0.13 | 1.0E-5 | NA | |
44 | hsa-let-7b-3p | PRKAA2 | 0.31 | 0.68425 | -0.18 | 0.67689 | mirMAP | -0.21 | 0.01354 | NA | |
45 | hsa-let-7b-5p | PRKAA2 | 0.4 | 0.78341 | -0.18 | 0.67689 | miRNAWalker2 validate; MirTarget | -0.2 | 0.00992 | NA | |
46 | hsa-miR-150-3p | PRKAA2 | -0.42 | 0.37145 | -0.18 | 0.67689 | MirTarget; miRNATAP | -0.11 | 0.02408 | NA | |
47 | hsa-miR-195-3p | PRKAA2 | -0.16 | 0.71189 | -0.18 | 0.67689 | mirMAP | -0.22 | 0.00097 | NA | |
48 | hsa-miR-21-3p | PRKAA2 | 0.13 | 0.87791 | -0.18 | 0.67689 | mirMAP | -0.19 | 0.00316 | NA | |
49 | hsa-miR-214-5p | PRKAA2 | 0.41 | 0.38386 | -0.18 | 0.67689 | MirTarget | -0.15 | 0.01379 | NA | |
50 | hsa-miR-141-3p | RHEB | -0.37 | 0.42836 | 0.19 | 0.74355 | MirTarget; TargetScan; miRNATAP | -0.11 | 0.00269 | NA | |
51 | hsa-miR-342-3p | RICTOR | -0.23 | 0.73996 | -0.28 | 0.52193 | MirTarget; PITA; miRanda; miRNATAP | -0.12 | 0.0004 | NA | |
52 | hsa-miR-744-5p | RPS6 | -0.17 | 0.80204 | 0.34 | 0.71928 | miRNAWalker2 validate | -0.19 | 0.00159 | NA | |
53 | hsa-miR-125a-5p | RPS6KA1 | -0.01 | 0.99489 | 0.01 | 0.98982 | MirTarget; PITA; miRanda | -0.23 | 0.00082 | NA | |
54 | hsa-miR-125b-5p | RPS6KA1 | 0.01 | 0.99415 | 0.01 | 0.98982 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.0014 | NA | |
55 | hsa-miR-17-5p | RPS6KA2 | -0.64 | 0.32067 | -0.1 | 0.85218 | TargetScan | -0.14 | 0.00238 | NA | |
56 | hsa-miR-636 | RPS6KA2 | -0.11 | 0.71062 | -0.1 | 0.85218 | MirTarget | -0.12 | 0.00485 | NA | |
57 | hsa-miR-181c-5p | RPS6KA3 | -0.26 | 0.64547 | -0.02 | 0.97429 | MirTarget; mirMAP; miRNATAP | -0.13 | 7.0E-5 | NA | |
58 | hsa-miR-125a-5p | RPS6KB2 | -0.01 | 0.99489 | -0 | 0.99992 | miRanda | -0.19 | 0.00028 | NA | |
59 | hsa-let-7d-5p | ULK2 | 0.01 | 0.98839 | -0.47 | 0.24243 | MirTarget | -0.15 | 0.00122 | NA | |
60 | hsa-let-7f-1-3p | ULK2 | 0.13 | 0.68644 | -0.47 | 0.24243 | MirTarget | -0.11 | 0.00372 | NA | |
61 | hsa-miR-1266-5p | ULK2 | 0.19 | 0.74972 | -0.47 | 0.24243 | MirTarget | -0.11 | 0.00404 | NA | |
62 | hsa-miR-326 | ULK3 | 0.31 | 0.65358 | -0.05 | 0.92018 | miRanda | -0.17 | 0 | NA | |
63 | hsa-miR-491-5p | ULK3 | -0.18 | 0.55955 | -0.05 | 0.92018 | miRanda | -0.13 | 0.00609 | NA | |
64 | hsa-miR-744-5p | ULK3 | -0.17 | 0.80204 | -0.05 | 0.92018 | miRNAWalker2 validate | -0.21 | 0.00012 | NA | |
65 | hsa-miR-129-5p | VEGFA | 0.42 | 0.45424 | -0.63 | 0.34942 | miRanda | -0.11 | 0.00029 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | INTRACELLULAR SIGNAL TRANSDUCTION | 19 | 1572 | 3.228e-15 | 1.502e-11 |
2 | PROTEIN PHOSPHORYLATION | 16 | 944 | 9.563e-15 | 2.225e-11 |
3 | PHOSPHORYLATION | 17 | 1228 | 2.536e-14 | 3.933e-11 |
4 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 11 | 354 | 7.511e-13 | 8.737e-10 |
5 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 18 | 1977 | 3.753e-12 | 3.493e-09 |
6 | PEPTIDYL SERINE MODIFICATION | 8 | 148 | 2.038e-11 | 1.499e-08 |
7 | REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 5 | 17 | 2.256e-11 | 1.499e-08 |
8 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 11 | 498 | 2.995e-11 | 1.742e-08 |
9 | CELLULAR RESPONSE TO HORMONE STIMULUS | 11 | 552 | 9.001e-11 | 4.653e-08 |
10 | REGULATION OF GLUCOSE IMPORT | 6 | 60 | 2.018e-10 | 9.389e-08 |
11 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 12 | 799 | 2.57e-10 | 1.021e-07 |
12 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 10 | 448 | 2.633e-10 | 1.021e-07 |
13 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 10 | 505 | 8.412e-10 | 3.011e-07 |
14 | CELLULAR RESPONSE TO INSULIN STIMULUS | 7 | 146 | 9.955e-10 | 3.088e-07 |
15 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 11 | 689 | 9.43e-10 | 3.088e-07 |
16 | POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 4 | 12 | 1.509e-09 | 4.389e-07 |
17 | CELLULAR RESPONSE TO PEPTIDE | 8 | 274 | 2.747e-09 | 7.518e-07 |
18 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 5 | 42 | 3.027e-09 | 7.826e-07 |
19 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 15 | 1848 | 3.384e-09 | 8.287e-07 |
20 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 12 | 1008 | 3.62e-09 | 8.421e-07 |
21 | REGULATION OF GLUCOSE TRANSPORT | 6 | 100 | 4.626e-09 | 1.025e-06 |
22 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 15 | 1929 | 6.117e-09 | 1.294e-06 |
23 | RESPONSE TO INSULIN | 7 | 205 | 1.058e-08 | 2.056e-06 |
24 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 13 | 1381 | 1.078e-08 | 2.056e-06 |
25 | NEGATIVE REGULATION OF CELL DEATH | 11 | 872 | 1.104e-08 | 2.056e-06 |
26 | RESPONSE TO HORMONE | 11 | 893 | 1.413e-08 | 2.529e-06 |
27 | REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 5 | 59 | 1.753e-08 | 2.913e-06 |
28 | INOSITOL LIPID MEDIATED SIGNALING | 6 | 124 | 1.694e-08 | 2.913e-06 |
29 | REGULATION OF CELL DEATH | 13 | 1472 | 2.319e-08 | 3.721e-06 |
30 | POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 4 | 23 | 2.671e-08 | 4.143e-06 |
31 | REGULATION OF TOR SIGNALING | 5 | 68 | 3.618e-08 | 5.431e-06 |
32 | PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 4 | 25 | 3.809e-08 | 5.538e-06 |
33 | CELL DEATH | 11 | 1001 | 4.575e-08 | 6.451e-06 |
34 | RESPONSE TO PEPTIDE | 8 | 404 | 5.644e-08 | 7.724e-06 |
35 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 13 | 1618 | 7.145e-08 | 9.498e-06 |
36 | INSULIN RECEPTOR SIGNALING PATHWAY | 5 | 80 | 8.249e-08 | 1.066e-05 |
37 | REGULATION OF LIPID METABOLIC PROCESS | 7 | 282 | 9.452e-08 | 1.189e-05 |
38 | RESPONSE TO NITROGEN COMPOUND | 10 | 859 | 1.315e-07 | 1.61e-05 |
39 | REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 5 | 89 | 1.412e-07 | 1.685e-05 |
40 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 4 | 36 | 1.755e-07 | 2.041e-05 |
41 | RESPONSE TO ENDOGENOUS STIMULUS | 12 | 1450 | 2.055e-07 | 2.332e-05 |
42 | REGULATION OF CELL CYCLE | 10 | 949 | 3.316e-07 | 3.506e-05 |
43 | REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS | 4 | 42 | 3.315e-07 | 3.506e-05 |
44 | REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 4 | 42 | 3.315e-07 | 3.506e-05 |
45 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 5 | 118 | 5.788e-07 | 5.985e-05 |
46 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 4 | 49 | 6.234e-07 | 6.043e-05 |
47 | REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 4 | 49 | 6.234e-07 | 6.043e-05 |
48 | REGULATION OF ATP METABOLIC PROCESS | 4 | 49 | 6.234e-07 | 6.043e-05 |
49 | REGULATION OF COENZYME METABOLIC PROCESS | 4 | 50 | 6.769e-07 | 6.3e-05 |
50 | REGULATION OF COFACTOR METABOLIC PROCESS | 4 | 50 | 6.769e-07 | 6.3e-05 |
51 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 12 | 1656 | 8.649e-07 | 7.891e-05 |
52 | TOR SIGNALING | 3 | 16 | 1.359e-06 | 0.0001216 |
53 | TRANSLATIONAL INITIATION | 5 | 146 | 1.661e-06 | 0.0001431 |
54 | POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 3 | 17 | 1.649e-06 | 0.0001431 |
55 | RESPONSE TO ACTIVITY | 4 | 69 | 2.495e-06 | 0.0002111 |
56 | POSITIVE REGULATION OF CELL COMMUNICATION | 11 | 1532 | 3.254e-06 | 0.0002698 |
57 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 74 | 3.305e-06 | 0.0002698 |
58 | GLUCOSE HOMEOSTASIS | 5 | 170 | 3.509e-06 | 0.0002721 |
59 | POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 4 | 75 | 3.488e-06 | 0.0002721 |
60 | CARBOHYDRATE HOMEOSTASIS | 5 | 170 | 3.509e-06 | 0.0002721 |
61 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 172 | 3.716e-06 | 0.0002834 |
62 | RESPONSE TO OXYGEN LEVELS | 6 | 311 | 3.804e-06 | 0.0002855 |
63 | CELLULAR RESPONSE TO STRESS | 11 | 1565 | 4.006e-06 | 0.0002958 |
64 | POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 3 | 24 | 4.877e-06 | 0.0003491 |
65 | POSITIVE REGULATION OF ATP METABOLIC PROCESS | 3 | 24 | 4.877e-06 | 0.0003491 |
66 | REGULATION OF CATABOLIC PROCESS | 8 | 731 | 4.975e-06 | 0.0003507 |
67 | CELL CYCLE | 10 | 1316 | 6.454e-06 | 0.0004482 |
68 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 4 | 88 | 6.609e-06 | 0.0004495 |
69 | RESPONSE TO ABIOTIC STIMULUS | 9 | 1024 | 6.666e-06 | 0.0004495 |
70 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 9 | 1036 | 7.327e-06 | 0.0004802 |
71 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 9 | 1036 | 7.327e-06 | 0.0004802 |
72 | REGULATION OF KINASE ACTIVITY | 8 | 776 | 7.717e-06 | 0.0004987 |
73 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 6 | 360 | 8.793e-06 | 0.0005605 |
74 | NEGATIVE REGULATION OF TOR SIGNALING | 3 | 30 | 9.727e-06 | 0.0006116 |
75 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 5 | 211 | 1.005e-05 | 0.0006237 |
76 | POSITIVE REGULATION OF GENE EXPRESSION | 11 | 1733 | 1.073e-05 | 0.0006532 |
77 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 9 | 1087 | 1.081e-05 | 0.0006532 |
78 | PEPTIDYL AMINO ACID MODIFICATION | 8 | 841 | 1.388e-05 | 0.0008279 |
79 | PROTEIN KINASE B SIGNALING | 3 | 34 | 1.428e-05 | 0.0008413 |
80 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 8 | 867 | 1.731e-05 | 0.001007 |
81 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 4 | 120 | 2.258e-05 | 0.001297 |
82 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 3 | 40 | 2.345e-05 | 0.001331 |
83 | NEGATIVE REGULATION OF CELL CYCLE | 6 | 433 | 2.501e-05 | 0.001402 |
84 | NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 4 | 131 | 3.186e-05 | 0.001765 |
85 | REGULATION OF TRANSFERASE ACTIVITY | 8 | 946 | 3.243e-05 | 0.001775 |
86 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 4 | 138 | 3.907e-05 | 0.002114 |
87 | REGULATION OF LIPID KINASE ACTIVITY | 3 | 48 | 4.075e-05 | 0.002179 |
88 | PLATELET ACTIVATION | 4 | 142 | 4.368e-05 | 0.002284 |
89 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 4 | 142 | 4.368e-05 | 0.002284 |
90 | IMMUNE EFFECTOR PROCESS | 6 | 486 | 4.773e-05 | 0.002467 |
91 | T CELL RECEPTOR SIGNALING PATHWAY | 4 | 146 | 4.869e-05 | 0.002489 |
92 | POSITIVE REGULATION OF CELL GROWTH | 4 | 148 | 5.134e-05 | 0.002595 |
93 | REGULATION OF LIPID CATABOLIC PROCESS | 3 | 52 | 5.187e-05 | 0.002595 |
94 | CELL CYCLE ARREST | 4 | 154 | 5.994e-05 | 0.002926 |
95 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 4 | 154 | 5.994e-05 | 0.002926 |
96 | AMIDE BIOSYNTHETIC PROCESS | 6 | 507 | 6.037e-05 | 0.002926 |
97 | POSITIVE REGULATION OF CELL ACTIVATION | 5 | 311 | 6.45e-05 | 0.003094 |
98 | REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 3 | 61 | 8.376e-05 | 0.003977 |
99 | LIPID BIOSYNTHETIC PROCESS | 6 | 539 | 8.469e-05 | 0.00398 |
100 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 6 | 552 | 9.656e-05 | 0.004493 |
101 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 10 | 1805 | 0.0001003 | 0.004576 |
102 | REGULATION OF TRANSPORT | 10 | 1804 | 9.984e-05 | 0.004576 |
103 | RESPONSE TO EXTERNAL STIMULUS | 10 | 1821 | 0.0001081 | 0.004882 |
104 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 3 | 67 | 0.0001109 | 0.00496 |
105 | CELL ACTIVATION | 6 | 568 | 0.000113 | 0.005006 |
106 | PEPTIDE METABOLIC PROCESS | 6 | 571 | 0.0001163 | 0.005057 |
107 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 3 | 68 | 0.0001159 | 0.005057 |
108 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 8 | 1135 | 0.0001176 | 0.005066 |
109 | FATTY ACID HOMEOSTASIS | 2 | 12 | 0.0001237 | 0.005279 |
110 | REGULATION OF CELL DIFFERENTIATION | 9 | 1492 | 0.0001312 | 0.005499 |
111 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 9 | 1492 | 0.0001312 | 0.005499 |
112 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 4 | 193 | 0.0001436 | 0.005964 |
113 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 5 | 370 | 0.000146 | 0.006012 |
114 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 4 | 195 | 0.0001494 | 0.006096 |
115 | CHEMICAL HOMEOSTASIS | 7 | 874 | 0.0001571 | 0.006259 |
116 | POSITIVE REGULATION OF CELL ADHESION | 5 | 376 | 0.0001574 | 0.006259 |
117 | RESPIRATORY SYSTEM DEVELOPMENT | 4 | 197 | 0.0001553 | 0.006259 |
118 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 7 | 876 | 0.0001593 | 0.006283 |
119 | INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 14 | 0.0001702 | 0.006656 |
120 | LYMPHOCYTE COSTIMULATION | 3 | 78 | 0.0001743 | 0.006757 |
121 | ERBB SIGNALING PATHWAY | 3 | 79 | 0.000181 | 0.006959 |
122 | FC RECEPTOR SIGNALING PATHWAY | 4 | 206 | 0.0001844 | 0.006975 |
123 | REGULATION OF INTRACELLULAR TRANSPORT | 6 | 621 | 0.0001838 | 0.006975 |
124 | REGULATION OF CELL GROWTH | 5 | 391 | 0.0001888 | 0.007029 |
125 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 4 | 207 | 0.0001878 | 0.007029 |
126 | LIPID MODIFICATION | 4 | 210 | 0.0001985 | 0.007214 |
127 | AUTOPHAGY | 5 | 394 | 0.0001956 | 0.007214 |
128 | REGULATION OF CELL ADHESION | 6 | 629 | 0.000197 | 0.007214 |
129 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 4 | 211 | 0.0002021 | 0.007234 |
130 | REGULATION OF TRANSLATIONAL INITIATION | 3 | 82 | 0.0002021 | 0.007234 |
131 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 4 | 213 | 0.0002095 | 0.007442 |
132 | IMMUNE SYSTEM PROCESS | 10 | 1984 | 0.000221 | 0.007792 |
133 | POSITIVE REGULATION OF TRANSPORT | 7 | 936 | 0.0002398 | 0.008388 |
134 | REGULATION OF ENERGY HOMEOSTASIS | 2 | 17 | 0.0002537 | 0.008745 |
135 | POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 2 | 17 | 0.0002537 | 0.008745 |
136 | POSITIVE REGULATION OF LOCOMOTION | 5 | 420 | 0.0002631 | 0.008934 |
137 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 8 | 1275 | 0.0002627 | 0.008934 |
138 | CELL PROLIFERATION | 6 | 672 | 0.0002816 | 0.009412 |
139 | CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 2 | 18 | 0.0002852 | 0.009412 |
140 | RESPONSE TO CAFFEINE | 2 | 18 | 0.0002852 | 0.009412 |
141 | ACTIVATION OF IMMUNE RESPONSE | 5 | 427 | 0.0002839 | 0.009412 |
142 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 4 | 235 | 0.0003048 | 0.009987 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | KINASE ACTIVITY | 16 | 842 | 1.605e-15 | 1.491e-12 |
2 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 445 | 7.612e-15 | 3.536e-12 |
3 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 16 | 992 | 2.068e-14 | 6.405e-12 |
4 | PROTEIN KINASE ACTIVITY | 13 | 640 | 7.876e-13 | 1.829e-10 |
5 | KINASE BINDING | 10 | 606 | 4.859e-09 | 9.028e-07 |
6 | ADENYL NUCLEOTIDE BINDING | 13 | 1514 | 3.245e-08 | 5.024e-06 |
7 | RIBONUCLEOTIDE BINDING | 14 | 1860 | 3.945e-08 | 5.236e-06 |
8 | ENZYME BINDING | 13 | 1737 | 1.649e-07 | 1.915e-05 |
9 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 4 | 43 | 3.652e-07 | 3.77e-05 |
10 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 4 | 51 | 7.338e-07 | 6.817e-05 |
11 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 4 | 70 | 2.644e-06 | 0.0002233 |
12 | INSULIN RECEPTOR BINDING | 3 | 32 | 1.186e-05 | 0.0009183 |
13 | PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 3 | 39 | 2.171e-05 | 0.001552 |
14 | TRANSLATION INITIATION FACTOR ACTIVITY | 3 | 51 | 4.892e-05 | 0.003246 |
15 | PHOSPHATASE BINDING | 4 | 162 | 7.297e-05 | 0.00452 |
16 | RNA CAP BINDING | 2 | 13 | 0.000146 | 0.008479 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 4 | 20 | 1.466e-08 | 8.56e-06 |
2 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 6 | 237 | 7.871e-07 | 0.0002298 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04150_mTOR_signaling_pathway | 28 | 52 | 4.935e-77 | 8.884e-75 | |
2 | hsa04151_PI3K_AKT_signaling_pathway | 21 | 351 | 7.841e-32 | 7.057e-30 | |
3 | hsa04910_Insulin_signaling_pathway | 16 | 138 | 3.053e-28 | 1.832e-26 | |
4 | hsa04914_Progesterone.mediated_oocyte_maturation | 11 | 87 | 1.108e-19 | 4.984e-18 | |
5 | hsa04722_Neurotrophin_signaling_pathway | 10 | 127 | 8.855e-16 | 3.188e-14 | |
6 | hsa04510_Focal_adhesion | 11 | 200 | 1.404e-15 | 4.211e-14 | |
7 | hsa04012_ErbB_signaling_pathway | 9 | 87 | 2.353e-15 | 6.05e-14 | |
8 | hsa04370_VEGF_signaling_pathway | 8 | 76 | 8.7e-14 | 1.958e-12 | |
9 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 7 | 42 | 1.219e-13 | 2.438e-12 | |
10 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 8 | 95 | 5.514e-13 | 9.925e-12 | |
11 | hsa04662_B_cell_receptor_signaling_pathway | 7 | 75 | 8.701e-12 | 1.424e-10 | |
12 | hsa04664_Fc_epsilon_RI_signaling_pathway | 7 | 79 | 1.266e-11 | 1.899e-10 | |
13 | hsa04014_Ras_signaling_pathway | 9 | 236 | 2.164e-11 | 2.996e-10 | |
14 | hsa04973_Carbohydrate_digestion_and_absorption | 6 | 44 | 2.889e-11 | 3.714e-10 | |
15 | hsa04620_Toll.like_receptor_signaling_pathway | 7 | 102 | 7.897e-11 | 9.476e-10 | |
16 | hsa04660_T_cell_receptor_signaling_pathway | 7 | 108 | 1.186e-10 | 1.334e-09 | |
17 | hsa04380_Osteoclast_differentiation | 7 | 128 | 3.946e-10 | 4.178e-09 | |
18 | hsa04210_Apoptosis | 6 | 89 | 2.279e-09 | 2.279e-08 | |
19 | hsa04062_Chemokine_signaling_pathway | 7 | 189 | 6.028e-09 | 5.71e-08 | |
20 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 6.434e-08 | 5.791e-07 | |
21 | hsa04140_Regulation_of_autophagy | 4 | 34 | 1.384e-07 | 1.187e-06 | |
22 | hsa04114_Oocyte_meiosis | 5 | 114 | 4.875e-07 | 3.989e-06 | |
23 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 5 | 136 | 1.17e-06 | 9.159e-06 | |
24 | hsa04010_MAPK_signaling_pathway | 6 | 268 | 1.61e-06 | 1.207e-05 | |
25 | hsa04920_Adipocytokine_signaling_pathway | 4 | 68 | 2.353e-06 | 1.694e-05 | |
26 | hsa04720_Long.term_potentiation | 4 | 70 | 2.644e-06 | 1.83e-05 | |
27 | hsa04070_Phosphatidylinositol_signaling_system | 4 | 78 | 4.081e-06 | 2.721e-05 | |
28 | hsa04810_Regulation_of_actin_cytoskeleton | 5 | 214 | 1.076e-05 | 6.92e-05 | |
29 | hsa04670_Leukocyte_transendothelial_migration | 4 | 117 | 2.043e-05 | 0.0001268 | |
30 | hsa03013_RNA_transport | 4 | 152 | 5.696e-05 | 0.0003418 | |
31 | hsa04730_Long.term_depression | 2 | 70 | 0.004304 | 0.02499 | |
32 | hsa04350_TGF.beta_signaling_pathway | 2 | 85 | 0.00628 | 0.03533 | |
33 | hsa04530_Tight_junction | 2 | 133 | 0.01482 | 0.08082 |